Skip to main content

Peer Review reports

From: Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma

Original Submission
7 Feb 2018 Submitted Original manuscript
16 Apr 2018 Author responded Author comments - Dennis Lindenblatt
Resubmission - Version 2
16 Apr 2018 Submitted Manuscript version 2
6 Jun 2018 Reviewed Reviewer Report - Hiroaki Itamochi
13 Jul 2018 Reviewed Reviewer Report - Reviewer 2
13 Aug 2018 Author responded Author comments - Dennis Lindenblatt
Resubmission - Version 3
13 Aug 2018 Submitted Manuscript version 3
19 Aug 2018 Reviewed Reviewer Report - Hiroaki Itamochi
14 Sep 2018 Author responded Author comments - Dennis Lindenblatt
Resubmission - Version 4
14 Sep 2018 Submitted Manuscript version 4
Publishing
19 Sep 2018 Editorially accepted
25 Sep 2018 Article published 10.1186/s12885-018-4836-1

You can find further information about peer review here.

Back to article page